
Verily, Alphabet's life sciences arm, has paused work on its so-called "smart lens" program, which was aiming to put tiny sensors on contact lenses to measure blood sugar levels in tears. If it worked, the lenses could help diabetics track their glucose levels in real time and in less invasive ways than the traditional meters that require piercing the skin. But in a blog post on Friday, Verily said that after four years of research it has determined that detecting blood sugar in tears is a massive — and potentially insurmountable — technical and scientific undertaking.
Read more:
https://www.cnbc.com/2018/11/16/alphabet-verily-stops-smart-lens-glucose-measuring-contact-lens.html?source=Snapzu
No comments:
Post a Comment